The health sector will remain a rich field of activity as we move into 2012. Companies of equipment and medical supplies will sought acquisitions and expand its market share in a consolidating market driven by a need for critical mass and new technologies. The pharmaceutical industry also continues making it difficult to consolidate repayment of returns of new products, R & D pipeline is narrow, and most governments seek to reduce spending pushing prices down. The decline in customers and the oversupply of contract manufacturers and clinical research organizations push the sector to consolidate through the supply chain. The social sector and health has always been a hot spot for investors and the market remains fragmented. The long-term fundamentals for the market of care services at home remain strong. The reduction of local government spending, growth in incomes, the increasing focus on alternative methods of care, an uncertain regulatory environment and increased operating costs contributed to a perfect storm that has landed in the companies. medical supplies The increased ratio of insolvency and moderate inflation will continue to impact on operating costs. Looking to M & A perspective based operations is a private initiative, reducing reliance on funding from public funds. Also, technologies that reduce operating costs will be a hot spot not to lose sight of. Therefore we expect that the spectrum of health care providers is subject to strong M & A activity, both in care services, specialists, medical supplies and equipment, as in pharmaceutical outsourcing. medical supplies The industry expects strong growth from 220 billion € in 2009 to 272 in 2014, representing a growth of 19.5 in the period.